\BOOKMARK [1][-]{section.1}{Abstract}{}% 1
\BOOKMARK [1][-]{section.2}{Introduction}{}% 2
\BOOKMARK [1][-]{section.3}{Methods}{}% 3
\BOOKMARK [2][-]{subsection.3.1}{Study\040population}{section.3}% 4
\BOOKMARK [2][-]{subsection.3.2}{Biweekly\040surveillance\040of\040RSV\040infection}{section.3}% 5
\BOOKMARK [2][-]{subsection.3.3}{Descriptive\040analyses}{section.3}% 6
\BOOKMARK [2][-]{subsection.3.4}{Host\040DNA\040Collection\040and\040Genotyping}{section.3}% 7
\BOOKMARK [2][-]{subsection.3.5}{Genetic\040Analyses\040of\040RSV\040Infection\040in\040Infancy}{section.3}% 8
\BOOKMARK [2][-]{subsection.3.6}{RSV\040whole-genome\040sequencing}{section.3}% 9
\BOOKMARK [2][-]{subsection.3.7}{Viral\040Sequence\040alignment}{section.3}% 10
\BOOKMARK [2][-]{subsection.3.8}{Population\040structure}{section.3}% 11
\BOOKMARK [2][-]{subsection.3.9}{Association\040testing}{section.3}% 12
\BOOKMARK [2][-]{subsection.3.10}{Biological\040interpretation}{section.3}% 13
\BOOKMARK [1][-]{section.4}{Results}{}% 14
\BOOKMARK [2][-]{subsection.4.1}{Cohort\040characteristics}{section.4}% 15
\BOOKMARK [2][-]{subsection.4.2}{Host\040Genetic\040Analyses}{section.4}% 16
\BOOKMARK [2][-]{subsection.4.3}{Population\040structure}{section.4}% 17
\BOOKMARK [2][-]{subsection.4.4}{Genetic\040invariance\040of\040prolonged\040infection}{section.4}% 18
\BOOKMARK [2][-]{subsection.4.5}{Variants\040in\040G\040glycoprotein\040significantly\040associated\040with\040prolonged\040infection}{section.4}% 19
\BOOKMARK [2][-]{subsection.4.6}{Functional\040interpretation}{section.4}% 20
\BOOKMARK [2][-]{subsection.4.7}{Clinical\040and\040interferon\040response}{section.4}% 21
\BOOKMARK [1][-]{section.5}{Discussion}{}% 22
\BOOKMARK [1][-]{section.6}{Links}{}% 23
\BOOKMARK [2][-]{subsection.6.1}{Software}{section.6}% 24
\BOOKMARK [2][-]{subsection.6.2}{Data\040sources}{section.6}% 25
\BOOKMARK [1][-]{section.7}{Code\040availability}{}% 26
\BOOKMARK [1][-]{section.8}{On-line\040supplement\040Methods:}{}% 27
\BOOKMARK [2][-]{subsection.8.1}{Host\040GWAS\040for\040genetic\040susceptibility\040to\040infection}{section.8}% 28
\BOOKMARK [1][-]{section.9}{Supplemental}{}% 29
